- Home
- PTGX vs SGHC Comparison
PTGX vs SGHC Comparison
Compare PTGX & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- SGHC
- Stock Information
- Founded
- PTGX 2006
- SGHC 2020
- Country
- PTGX United States
- SGHC Guernsey
- Employees
- PTGX N/A
- SGHC N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- SGHC Services-Misc. Amusement & Recreation
- Sector
- PTGX Health Care
- SGHC Consumer Discretionary
- Exchange
- PTGX Nasdaq
- SGHC Nasdaq
- Market Cap
- PTGX 4.0B
- SGHC 6.6B
- IPO Year
- PTGX 2016
- SGHC N/A
- Fundamental
- Price
- PTGX $73.96
- SGHC $12.05
- Analyst Decision
- PTGX Strong Buy
- SGHC Strong Buy
- Analyst Count
- PTGX 8
- SGHC 8
- Target Price
- PTGX $74.13
- SGHC $15.50
- AVG Volume (30 Days)
- PTGX 1.6M
- SGHC 2.4M
- Earning Date
- PTGX 11-06-2025
- SGHC 11-03-2025
- Dividend Yield
- PTGX N/A
- SGHC 1.28%
- EPS Growth
- PTGX N/A
- SGHC 1999.69
- EPS
- PTGX 0.80
- SGHC 0.29
- Revenue
- PTGX $209,180,000.00
- SGHC $2,230,781,944.00
- Revenue This Year
- PTGX N/A
- SGHC $25.57
- Revenue Next Year
- PTGX $243.08
- SGHC $8.11
- P/E Ratio
- PTGX $93.23
- SGHC $42.02
- Revenue Growth
- PTGX N/A
- SGHC 37.19
- 52 Week Low
- PTGX $33.31
- SGHC $4.01
- 52 Week High
- PTGX $93.25
- SGHC $14.38
- Technical
- Relative Strength Index (RSI)
- PTGX 56.90
- SGHC 42.29
- Support Level
- PTGX $74.62
- SGHC $12.95
- Resistance Level
- PTGX $77.66
- SGHC $13.74
- Average True Range (ATR)
- PTGX 4.74
- SGHC 0.50
- MACD
- PTGX -0.04
- SGHC -0.21
- Stochastic Oscillator
- PTGX 38.21
- SGHC 6.24
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.